Sessions from the 11th WFH Global Forum will cover the latest developments in treatment and research including:

  • Blood and plasma safety
  • Extended half-life products
  • Non-factor products
  • Ensuring access to affordable treatment products and humanitarian aid
  • Gene and cell therapy
  • New and novel hemophilia therapies
  • Von Willebrand Disease & Women and bleeding disorders
  • WFH data collection programs

The program can be viewed here.

The 11th WFH Global Forum is supported by funding from:
Additional support: